Key Information
summary/abstract
A case-based review of diagnostic algorithms and transthyretin (TTR) therapies for cardiac amyloidosis, featuring expert guidance on navigating Veterans Affairs (VA) and federal system challenges.
Cardiac amyloidosis is an increasingly recognized cause of heart failure and other cardiovascular syndromes yet remains underdiagnosed and challenging to manage. This webinar, hosted by ACC's Federal Cardiology Member Section, provides a practical, case-based review of contemporary strategies for identifying, diagnosing and treating cardiac amyloidosis, with an emphasis on TTR disease. Expert faculty will review diagnostic algorithms, imaging pitfalls and real-world treatment considerations, including VA and federal system challenges.